M David

679 total citations
24 papers, 518 citations indexed

About

M David is a scholar working on Surgery, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, M David has authored 24 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Oncology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in M David's work include Radiation Dose and Imaging (3 papers), Metabolism and Genetic Disorders (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). M David is often cited by papers focused on Radiation Dose and Imaging (3 papers), Metabolism and Genetic Disorders (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). M David collaborates with scholars based in Israel, United States and France. M David's co-authors include Geertjan van Tienhoven, J Mansi, J Hardy, Peter Simmonds, Renaud Léonard, Gila Lithwick‐Yanai, Ram Eitan, Shai Rosenwald, Gad Sabah and Michal Kushnir and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and British Journal of Dermatology.

In The Last Decade

M David

22 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M David Israel 11 260 192 79 65 58 24 518
E. McGuinness Ireland 7 349 1.3× 273 1.4× 78 1.0× 120 1.8× 87 1.5× 13 558
Yanyan Zhuang China 14 326 1.3× 237 1.2× 52 0.7× 57 0.9× 112 1.9× 23 528
Mohammad Shekari Iran 15 185 0.7× 132 0.7× 65 0.8× 120 1.8× 109 1.9× 40 475
Aska Toda Japan 10 240 0.9× 189 1.0× 38 0.5× 62 1.0× 85 1.5× 21 470
Junjia Zhu China 10 218 0.8× 187 1.0× 72 0.9× 55 0.8× 126 2.2× 25 439
Antonio Traficante Italy 12 374 1.4× 167 0.9× 100 1.3× 49 0.8× 86 1.5× 30 614
Alfonso C. Almendral Switzerland 8 126 0.5× 181 0.9× 61 0.8× 61 0.9× 109 1.9× 15 446
Annette Schmider Germany 11 155 0.6× 108 0.6× 65 0.8× 28 0.4× 204 3.5× 18 476
RMC Busby-Earle United Kingdom 7 145 0.6× 82 0.4× 56 0.7× 105 1.6× 101 1.7× 9 448
Bo Wook Kim South Korea 11 257 1.0× 124 0.6× 84 1.1× 57 0.9× 185 3.2× 35 573

Countries citing papers authored by M David

Since Specialization
Citations

This map shows the geographic impact of M David's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M David with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M David more than expected).

Fields of papers citing papers by M David

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M David. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M David. The network helps show where M David may publish in the future.

Co-authorship network of co-authors of M David

This figure shows the co-authorship network connecting the top 25 collaborators of M David. A scholar is included among the top collaborators of M David based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M David. M David is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
David, M, et al.. (2018). Predictors of outcomes in managing breast abscesses-A large retrospective single-center analysis. The Breast Journal. 24(5). 755–763. 14 indexed citations
2.
Lawrence, Yaacov Richard, M David, Shira Galper, et al.. (2016). The Impact of a Detailed Checklist on Physician Peer Review in Radiation Oncology: A Prospective Study. International Journal of Radiation Oncology*Biology*Physics. 96(2). E544–E544. 1 indexed citations
3.
Fridman, Eddie, Zohar Dotan, Iris Barshack, et al.. (2010). Accurate Molecular Classification of Renal Tumors Using MicroRNA Expression. Journal of Molecular Diagnostics. 12(5). 687–696. 89 indexed citations
4.
Feiner, Benjamin, et al.. (2009). Does COLIA1 SP1-binding site polymorphism predispose women to pelvic organ prolapse?. International Urogynecology Journal. 20(9). 1061–1065. 23 indexed citations
5.
Eitan, Ram, Michal Kushnir, Gila Lithwick‐Yanai, et al.. (2009). Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients. Gynecologic Oncology. 114(2). 253–259. 122 indexed citations
6.
Leibman, A. Jill, et al.. (2007). Breast problems presenting in the emergency room. Emergency Radiology. 14(1). 23–28. 8 indexed citations
7.
Shohat, M., B. Shohat, Daniel Mimouni, et al.. (2006). Human T-cell lymphotropic virus type 1 provirus and phylogenetic analysis in patients with mycosis fungoides and their family relatives. British Journal of Dermatology. 155(2). 372–378. 8 indexed citations
8.
David, M. (2005). MUTCH, WALTER WAHLI, GARY WILLIAMSON. NUTRIGENOMICS AND NUTRIGENETICS: THE EMERGING FACES OF NUTRITION. 19(12). 1602–1616. 2 indexed citations
9.
Shohat, M., et al.. (2001). Cytokine Profile of Patients with Mycosis Fungoides and the Immunomodulatory Effect of AS101. Acta Dermato Venereologica. 81(4). 255–257. 9 indexed citations
10.
Léonard, Renaud, J Hardy, Geertjan van Tienhoven, et al.. (2001). Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of 6% Miltefosine Solution, a Topical Chemotherapy in Cutaneous Metastases From Breast Cancer. Journal of Clinical Oncology. 19(21). 4150–4159. 116 indexed citations
11.
Constans, J P, G Szikla, & M David. (1998). [Apropos of the therapeutic use of some radioactive elements (Aul 98 and Y90) in neurosurgery].. PubMed. 6. 113–27.
12.
Dar, Hanna, et al.. (1996). Maternal serum markers levels in consecutive pregnancies: A possible genetic predisposition to abnormal levels. American Journal of Medical Genetics. 61(2). 154–157. 16 indexed citations
13.
Torrisi, Jean, et al.. (1995). Fibrovascular Polyps of the Esophagus. Journal of Computer Assisted Tomography. 19(1). 157–159. 7 indexed citations
14.
David, M, et al.. (1995). Very Low Maternal Serum Unconjugated Estriol and Prenatal Diagnosis of Steroid Sulfatase Deficiency. Fetal Diagnosis and Therapy. 10(2). 76–80. 20 indexed citations
15.
Shohat, Mordechai, Bella Davidov, Gad Barkai, et al.. (1995). Amniocentesis rate and the detection of down syndrome and other chromosomal anomalies in Israel. Prenatal Diagnosis. 15(10). 967–970. 12 indexed citations
16.
Kleiman, Sandra E., Smadar Avigad, Lina Vanagaite, et al.. (1994). Origins of Hyperphenylalaninemiain Israel. European Journal of Human Genetics. 2(1). 24–34. 11 indexed citations
17.
Chauvergne, J, C. Lhommé, Y Aymé, et al.. (1993). [Neoadjuvant chemotherapy of stage IIb or III cancers of the uterine cervix. Long-term results of a multicenter randomized trial of 151 patients].. PubMed. 80(12). 1069–79. 21 indexed citations
18.
Ebert, A. & M David. (1991). [Carl Wilhelm Mayer (1795-1868)--founder of the Berlin Society of Obstetrics].. PubMed. 113(11). 653–60.
19.
Chauvergne, J, et al.. (1988). [A randomized study comparing cisplatin alone or combined in the palliative treatment of carcinoma of the head and neck. Analysis of a series of 209 patients].. PubMed. 75(1). 9–22. 8 indexed citations
20.
Chauvergne, J, et al.. (1986). [Chemotherapy of breast cancers. Coordinated evolution of therapeutic schemes from 1975 to 1985].. PubMed. 81(3). 119–22. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026